Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
PLoS One ; 18(7): e0286559, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37418442

RESUMO

Diabetic peripheral neuropathy is often classified as a loss of sensation in the extremities, particularly in elderly populations. The most common diagnosis technique is with the use of the hand-applied Semmes-Weinstein monofilament. This study's first aim was to quantify and compare sensation on the plantar surface in healthy and type 2 diabetes mellitus populations with the standard Semmes-Weinstein hand-applied methodology and a tool that automates this approach. The second was to evaluate correlations between sensation and the subjects' medical characteristics. Sensation was quantified by both tools, at thirteen locations per foot, in three populations: Group 1-control subjects without type 2 diabetes, Group 2-subjects with type 2 diabetes and with neuropathy symptoms, and Group 3-subjects with type 2 diabetes without neuropathy symptoms. The percentage of locations sensitive to the hand-applied monofilament, yet insensitive to the automated tool was calculated. Linear regression analyses between sensation and the subject's age, body mass index, ankle brachial index, and hyperglycemia metrics were performed per group. ANOVAs determined differences between populations. Approximately 22.5% of locations assessed were sensitive to the hand-applied monofilament, yet insensitive to the automated tool. Age and sensation were only significantly correlated in Group 1 (R2 = 0.3422, P = 0.004). Sensation was not significantly correlated with the other medical characteristics per group. Differences in sensation between the groups were not significant (P = 0.063). Caution is recommended when using hand-applied monofilaments. Group 1's sensation was correlated to age. The other medical characteristics failed to corelate with sensation, despite group.


Assuntos
Diabetes Mellitus Tipo 2 , Neuropatias Diabéticas , Humanos , Idoso , Diabetes Mellitus Tipo 2/complicações , Neuropatias Diabéticas/diagnóstico , Sensação , , Mãos
6.
Anesth Analg ; 114(3): 622-5, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22190557

RESUMO

BACKGROUND: Waterless antiseptic surgical hand scrub (1% chlorhexidine gluconate and 61% ethyl alcohol, Avagard™; 3M Health Care, St. Paul, MN), alcohol-only cleanser (62% ethyl alcohol), and traditional surgical scrub (5-minute scrub with 4% chlorhexidine soap using a sterile scrub brush with water) are techniques used for hand cleansing and disinfection. We hypothesized that alcohol-only cleanser and waterless antiseptic scrub (Avagard) would be as effective as a traditional surgical scrub for hand cleansing before placement of central venous catheters. METHODS: Fingers of subjects were plate-cultured for 24 hours after 5 methods of hand cleansing: method 1: traditional surgical scrub (n = 49 plates produced by 14 subjects); method 2: traditional surgical scrub (5-minute scrub with water, brush, and 4% chlorhexidine soap) followed by a 15-minute break, then alcohol-only cleanser (62% alcohol) (n = 49 plates produced by 14 subjects); method 3: alcohol-only cleanser alone (n = 49 plates produced by 14 subjects); method 4: alcohol-only cleanser (62% alcohol), followed by a 15-minute break, then traditional surgical scrub (5-minute scrub with brush, and 4% chlorhexidine soap with water) (n = 49 plates produced by 14 subjects); and method 5: waterless surgical scrub (Avagard) alone (n = 116 plates produced by 38 subjects). The 15-minute break was introduced to allow a short period of recontamination, and to test for residual effects from prior cleansing. RESULTS: Alcohol-only cleanser alone (method 3) was significantly less effective than the traditional surgical scrub (method 1) (P < 0.001; 82% plate growth). Waterless surgical scrub (Avagard) (method 5) had a 0% observed difference (95% confidence interval [CI]: -14% to 11%) compared with the traditional 5-minute scrub (method 1) (P = 0.99; 16% plate growth). When a traditional surgical scrub was used first followed by a 15-minute period of recontamination, there was a 6% observed difference in method 2 from reference (method 1) (95% CI: -10% to 22%), and 0% observed difference in method 4 from reference (95% CI: -15% to 15%). CONCLUSION: As the initial cleansing method, the alcohol-only cleanser (method 3) was significantly less effective than the traditional surgical scrub (method 1) (P < 0.001).


Assuntos
Cateterismo Venoso Central/normas , Desinfecção/normas , Etanol/administração & dosagem , Desinfecção das Mãos/normas , Anti-Infecciosos Locais/administração & dosagem , Clorexidina/administração & dosagem , Clorexidina/análogos & derivados , Contagem de Colônia Microbiana/métodos , Desinfecção/métodos , Feminino , Desinfecção das Mãos/métodos , Humanos , Masculino , Sabões/administração & dosagem
7.
Case Rep Transplant ; 2011: 263561, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-23213602

RESUMO

A 48-year-old patient with hypertensive end-stage renal disease presented for cadaveric renal transplantation. On physical exam, a previously undocumented diastolic murmur was heard loudest at the left lower sternal border. The patient had a history of pericardial effusions and reported "a feeling of chest fullness" when lying flat. As such, a transesophageal echocardiogram (TEE) was performed after induction of anesthesia to evaluate the pericardial space and possibly determine the etiology and severity of the new murmur. The TEE revealed a Stanford Type A aortic dissection. The renal transplant was cancelled (organ reassigned within region), and the patient underwent an urgent ascending and proximal hemiarch aortic replacement. This case demonstrates the importance of a thorough physical exam and highlights the utility of TEE for noncardiac surgical cases.

8.
J Am Soc Echocardiogr ; 24(2): 228.e1-2, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20650607

RESUMO

A 45-year-old woman with a history of rheumatic mitral disease underwent valve replacement. After surgery, the patient became hemodynamically unstable. A transesophageal echocardiogram showed an underfilled left ventricle with a clot impinging on the lateral aspect of the left ventricle and a malfunctioning mitral valve prosthesis. After evacuation of the clot in the operating room, the mitral valve prosthesis began functioning normally. The prosthesis malfunction resulted from external cardiac compression. This dynamic device malfunction was replicated when the surgeon compressed the lateral aspect of the heart. To our knowledge, this dynamic form of leaflet dysfunction from external compression has not been described. This case highlights the importance of closely evaluating prosthetic valve function in the setting of hemodynamic deterioration.


Assuntos
Próteses Valvulares Cardíacas/efeitos adversos , Insuficiência da Valva Mitral/diagnóstico por imagem , Insuficiência da Valva Mitral/etiologia , Falha de Prótese , Feminino , Humanos , Pessoa de Meia-Idade , Pressão , Ultrassonografia
11.
Anesth Analg ; 107(6): 1848-54, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19020129

RESUMO

Patients with congenital supravalvular aortic stenosis and associated peripheral pulmonary artery stenoses, the majority of whom have Williams-Beuren syndrome, are inherently at risk for development of myocardial ischemia. This is particularly true in the setting of procedural sedation and anesthesia. The biventricular hypertrophy that accompanies these lesions increases myocardial oxygen consumption and compromises oxygen delivery. In addition, these patients often have direct, multifactorial compromise of coronary blood flow. In this article, we review both the pathophysiology of congenital supravalvular aortic stenosis and the literature regarding sudden death in association with sedation and anesthesia. Recommendations as to preoperative assessment and management of these patients are made based on the best available evidence.


Assuntos
Anestesia/efeitos adversos , Estenose Aórtica Supravalvular/congênito , Morte Súbita Cardíaca/etiologia , Estenose Aórtica Supravalvular/complicações , Estenose Aórtica Supravalvular/fisiopatologia , Circulação Coronária , Estenose Coronária/etiologia , Humanos , Isquemia Miocárdica/etiologia , Síndrome de Williams/fisiopatologia
15.
Blood Coagul Fibrinolysis ; 18(7): 695-7, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17890960

RESUMO

Antiphospholipid syndrome is an autoimmune thrombophilic disorder that is uncommon in adults and remarkably rare in children. Thrombotic etiological factors are variable in antiphospholipid syndrome, including antibody-antigen complex-mediated platelet activation, inhibition of anticoagulants, or attenuation of fibrinolysis. We present the case of a child with antiphospholipid syndrome presenting with syncope, constrictive pericarditis and hepatic enlargement that was found to have platelet-mediated hypercoagulability and marked clot lysis via thrombelastography in the preoperative period. Restoration of circulation following pericardectomy and inotropic support was associated with attenuation of hypercoagulability and fibrinolysis. It is concluded that the etiological factors responsible for antiphospholipid syndrome-mediated hemostatic abnormalities and the probable effects of hepatic hypoperfusion on clot lysis in this patient were detected with thrombelastography, and similar thrombelastographic analyses are recommended to compliment standard coagulation assessments of patients with antiphospholipid syndrome.


Assuntos
Complexo Antígeno-Anticorpo/imunologia , Síndrome Antifosfolipídica/complicações , Transtornos da Coagulação Sanguínea/diagnóstico , Transtornos da Coagulação Sanguínea/imunologia , Pericardite Constritiva/complicações , Tromboelastografia , Adolescente , Síndrome Antifosfolipídica/sangue , Fibrinólise/imunologia , Hemostasia/imunologia , Insuficiência Hepática/imunologia , Humanos , Circulação Hepática/imunologia , Masculino , Pericardiectomia , Pericardite Constritiva/cirurgia , Reperfusão
16.
Anesth Analg ; 99(1): 120-123, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15281516

RESUMO

Fibrinogen has been shown to be responsible for most protein-mediated clot strength via thrombelastography. However, factor XIII (FXIII) activity also plays a prominent role in the development of clot strength. Thus, we hypothesized that changes in FXIII activity would significantly increase clot strength. FXIII (0%, 1%, 6.25%, 12.5%, 25%, 50%, and 100% normal activity) was placed in a fixed volume of citrated FXIII-deficient plasma with 1% tissue factor and calcium chloride and underwent thrombelastography for 10 min. We measured the variables reaction time (R; a measurement of clot initiation), alpha (a measure of the rate of clot formation), amplitude (A; a measure of clot strength), and shear elastic modulus (G; a measure of clot strength). FXIII activity significantly decreased R in a pattern of exponential decay (R2 = 0.77; P < 0.001). FXIII activity significantly increased alpha, following a sigmoidal pattern (R2 = 0.88; P < 0.001). Finally, increases in FXIII activity significantly increased A and G in a sigmoidal pattern (R = 0.89; P < 0.001). We concluded that FXHI significantly affects R, alpha, A, and G. Thus, transfusion decision making with protein-mediated thrombelastographic patterns must account for the contribution of both fibrinogen and FXIII.


Assuntos
Coagulação Sanguínea/efeitos dos fármacos , Fator XIII/farmacologia , Tromboelastografia , Relação Dose-Resposta a Droga , Elasticidade , Deficiência do Fator XIII/sangue , Humanos , Técnicas In Vitro , Cinética
17.
Artigo | PAHO-IRIS | ID: phr-47482

RESUMO

Meeting of the Advisory Committee on Medical Research, 7. Pan American Health Organization; 24-28 Jun. 1968


Assuntos
Pesquisa , Indígenas Norte-Americanos , Doenças da Bexiga Urinária , América Latina , Região do Caribe , Formulação de Políticas
19.
Artigo em Espanhol | PAHO | ID: pah-34769

RESUMO

A Pilot campaign against onchocerciasis based upon the administration of suramin sodium was conducted in Yepocapa, Chenaltenango, Guatemala. This caused a spectacular reduction in the incidence of persons with demonstrable microfilariae. Suramin administered orally to children was not effective


The suramin used in this trial was considerably more toxic than that used in preliminary studies. It is felt that the brand used in this pilot campaign should only be used on hospitalized patients or those with constant medical supervision. Future medical programs should use only well established brands such as those in constant use in Africa for the treatment of sleeping sickness(AU)


Assuntos
Oncocercose/tratamento farmacológico , Seguimentos , Guatemala
20.
Artigo em Espanhol | PAHO | ID: pah-34760

RESUMO

1. In preparation for a pilot project for the medical treatment of onchocerciasis with suramin (USP III) 1,142 inhabitants from Yepocapa, Chimaltenango, Guatemala, were examined for various manifestations of onchocerciasis


2. Approximately half of all adults examined had demonstrable microfilariae on skin biopsies. The youngest individuals with a positive biopsy was two years old


3. One fourth of the subjects examined had palpable nodules. Fifty-four per cent of the nodules were located on the head. The remaining were fairly evenly distributed between the thorax and pelvic region with but one per cent palpated on the arms or legs


4. The youngest patient on whom a nodule was proved to be onchocercal was a twenty-six month old child. A nodule was palpated on an eighteen month infant, but examination following excision proved it to be a hypertrophied lymph node


5. Twenty-six or 2.2 per cent of the population examined were blind in one of both eyes


6. Ocular symptoms consisting of entopic vision of worms, hazy vision and unpleasant sensations were encountered in approximately one fourth of the subjects interviewed


7. Visula acuity was diminished in a little more than one third and visual fields constricted in one eighth of the individuals tested


8. Examination with a hand slit lamp showed alterations of the conjunctiva and limbus in 15.9 per cent of the patients examined. ...(AU)


Assuntos
Oncocercose/epidemiologia , Oncocercose/prevenção & controle , Oncocercose/tratamento farmacológico , Suramina/terapia , Saúde Ocular , Projetos Piloto , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...